FR2003097A1 - Cpds. of general formula (I) A=CH or N Spasmolytics and peripheral vasodilators. Dose: 100-200 mg/d. (p.o). Z and X are OH or reactive - Google Patents

Cpds. of general formula (I) A=CH or N Spasmolytics and peripheral vasodilators. Dose: 100-200 mg/d. (p.o). Z and X are OH or reactive

Info

Publication number
FR2003097A1
FR2003097A1 FR6905260A FR6905260A FR2003097A1 FR 2003097 A1 FR2003097 A1 FR 2003097A1 FR 6905260 A FR6905260 A FR 6905260A FR 6905260 A FR6905260 A FR 6905260A FR 2003097 A1 FR2003097 A1 FR 2003097A1
Authority
FR
France
Prior art keywords
spasmolytics
cpds
dose
general formula
reactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6905260A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2003097A1 publication Critical patent/FR2003097A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR6905260A 1968-03-02 1969-02-28 Cpds. of general formula (I) A=CH or N Spasmolytics and peripheral vasodilators. Dose: 100-200 mg/d. (p.o). Z and X are OH or reactive Withdrawn FR2003097A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1373468 1968-03-02
JP4640568 1968-07-03

Publications (1)

Publication Number Publication Date
FR2003097A1 true FR2003097A1 (en) 1969-11-07

Family

ID=26349560

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6905260A Withdrawn FR2003097A1 (en) 1968-03-02 1969-02-28 Cpds. of general formula (I) A=CH or N Spasmolytics and peripheral vasodilators. Dose: 100-200 mg/d. (p.o). Z and X are OH or reactive

Country Status (4)

Country Link
BE (1) BE729170A (https=)
DE (1) DE1910481A1 (https=)
FR (1) FR2003097A1 (https=)
NL (1) NL6903138A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2509301A1 (fr) * 1981-04-15 1983-01-14 Crosara Farma Bilog Lab Compose nicotinate de cycloheptyle ayant une activite vasodilatatrice peripherique et utile comme rubefiant, procede pour sa preparation et compositions pharmaceutiques le contenant

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1060356B (it) * 1973-03-12 1982-07-10 Poli Ind Chimica Spa Estere nicotinico e composizione farmaceutica ad azione vasodilata trice spasmolitica e ipolipemizzante e processo per la preparazione di detto estere
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2509301A1 (fr) * 1981-04-15 1983-01-14 Crosara Farma Bilog Lab Compose nicotinate de cycloheptyle ayant une activite vasodilatatrice peripherique et utile comme rubefiant, procede pour sa preparation et compositions pharmaceutiques le contenant

Also Published As

Publication number Publication date
BE729170A (https=) 1969-08-01
NL6903138A (https=) 1969-09-04
DE1910481A1 (de) 1969-10-09

Similar Documents

Publication Publication Date Title
ZA721817B (en) Improvements in or relating to kits for assembling for example a piece of furniture,a partition or toys from panels and strips
IL48872A0 (en) Improvements in solar panels
FR2003097A1 (en) Cpds. of general formula (I) A=CH or N Spasmolytics and peripheral vasodilators. Dose: 100-200 mg/d. (p.o). Z and X are OH or reactive
ZA745865B (en) Improvements in or relating to board games
PT71815B (en) Process for improving the appearance of used in particularsoiled textiles
ZA766362B (en) Kitchen ventilator
ZA765955B (en) An improvement in or relating to non-exposed drawer lock
GB2033559B (en) Heat-insulating fibrous panels
ZA756341B (en) Improvements in or relating to constructional boards or panels
JPS5241936A (en) Panel heater
NZ180508A (en) Reinforced wooden panel
JPS51148953A (en) Linte l
ZA767228B (en) Improvements in or relating to buildings
AU1059376A (en) Composite wood cement panel
JPS51136792A (en) Flame resistant polyester preparation
JPS5220648A (en) Automatic door pocket
JPS521943A (en) Housing of opening and shutting type
ZA764568B (en) Improvements in or relating to building structures
JPS51146076A (en) Multi-stage shaft member storage apparatus
AU494982B2 (en) Improvements in or relating to cabinet structures
JPS5357558A (en) Clothing drier
JPS5252457A (en) Ventilating fan
HK71778A (en) Improvements in or relating to kites
AU494732B2 (en) Improvements in or relating to games balls
CA899640A (en) Condensate heating of intermediate strength solution in two stage absorption machine

Legal Events

Date Code Title Description
ST Notification of lapse